UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date:

March 25, 2026 4:30 P.M.

Form:

S-3

CIK:	0001604464
Company Name:	Atara Biotherapeutics, Inc.
File Number:	333-294377